Bacterial lipopolysaccharide (LPS) is widely used to study immune influences on the CNS, and cerebrovascular prostaglandin (PG) synthesis is implicated in mediating LPS influences on some acute phase responses. Other bacterial products, such as staphylococcal enterotoxin B (SEB), impact target tissues differently in that their effects are T-lymphocyte-dependent, yet both LPS and SEB recruit a partially overlapping set of subcortical central autonomic cell groups. We sought to compare neurovascular responses to the two pathogens, and the mechanisms by which they may access the brain. Rats received iv injections of LPS (2 lg/kg), SEB (1 mg/kg) or vehicle and were sacrificed 0.5-3 h later. Both challenges engaged vascular cells as early 0.5 h, as evidenced by induced expression of the vascular early response gene (Verge), and the immediate-early gene, NGFI-B. Cyclooxygenase-2 (COX-2) expression was detected in both endothelial and perivascular cells (PVCs) in response to LPS, but only in PVCs of SEB-challenged animals. The non-selective COX inhibitor, indomethacin (1 mg/kg, iv), blocked LPS-induced activation in a subset of central autonomic structures, but failed to alter SEB-driven responses. Liposome mediated ablation of PVCs modulated the CNS response to LPS, did not affect the SEB-induced activational profile. By contrast, disruptions of interoceptive signaling by area postrema lesions or vagotomy (complete or hepatic) markedly attenuated SEB-, but not LPS-, stimulated central activational responses. Despite partial overlap in their neuronal and vascular response profiles, LPS and SEB appear to use distinct mechanisms to access the brain.
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Introduction
During infection, cytokines released from activated immune cells act on the brain to elicit acute phase responses such as, fever, somnolence, anorexia, lethargy and metabolic effects, including activation of the hypothalamo-pituitary-adrenal (HPA) axis (Dantzer et al., 1998b; Dinarello, 1984 Dinarello, , 1988 Elmquist et al., 1997; Krueger et al., 1999) . Studies of immune system influences on the central nervous system (CNS) have commonly utilized administration of pathogen analogs such as lipopolysaccharide (LPS or endotoxin), a component of the Gram-negative bacterial cell wall, or cytokines themselves, to model the activation of the innate immune system (Elmquist and Saper, 1996; Elmquist et al., 1996; Ericsson et al., 1997; Rivest, 2001; Sapolsky et al., 1987; Schiltz and Sawchenko, 2002) . LPS or cytokines are bound by specific receptors on cells leading to cytokine production and/or release that activate secondary signaling mechanisms to influence the CNS.
Other models have been used to study the CNS impact of activating T-lymphocyte-dependent immune response. These include the use of superantigens, notably staphylococcal enterotoxins A (SEA) and B (SEB) (Proft and Fraser, 2003) , which are secreted products of Staphylococcus aureus implicated in food poisoning, toxic shock syndrome and autoimmune disease (Torres et al., 2001 ). Superantigens powerfully stimulate clonal expansion of T-lymphocytes bearing appropriate motifs on the variable domain of the b chain of the T-cell receptor in an antigen-independent manner, leading to clonal expansion of targeted T-cells and production of a panel of cytokines largely distinct from those stimulated by LPS (Muller-Alouf et al., 2001) .
Because neither SEB nor LPS cross the blood-brain-barrier in appreciable concentrations, the mechanisms by which they influence CNS function have been studied extensively and several routes have been proposed (Elmquist et al., 1997; Schiltz and Sawchenko, 2002; Wang et al., 2004; Watkins et al., 1995) . Entry at circumventricular organs, transduction by peripheral nerves, facilitated transport across the barrier, and cytokine-receptor interactions at the brain-fluid interfaces, have all been considered as a basis for such interactions (Dantzer, 1994; Ericsson et al., 1997; Watkins et al., 1995) . In the case of LPS, there is substantial evidence to support the view that increased circulating cytokines
